- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Recent updates on allogeneic CAR-T cells in hematological malignancies ; volume:24 ; number:1 ; day:3 ; month:9 ; year:2024 ; pages:1-22 ; date:12.2024
Cancer cell international ; 24, Heft 1 (3.9.2024), 1-22, 12.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
Mansoori, Shafieeh
Noei, Ahmad
Maali, Amirhosein
Seyed-Motahari, Seyedeh Sheila
Sharifzadeh, Zahra
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-024-03479-y
- URN
-
urn:nbn:de:101:1-2411261054437.983278027508
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mansoori, Shafieeh
- Noei, Ahmad
- Maali, Amirhosein
- Seyed-Motahari, Seyedeh Sheila
- Sharifzadeh, Zahra
- SpringerLink (Online service)
Other Objects (12)
Special issue: CAR‐T cell therapy for hematological malignancies
The journey of CAR-T therapy in hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Deubiquitinases in hematological malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
Special issue: CAR‐T cell therapy for hematological malignancies
The journey of CAR-T therapy in hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Deubiquitinases in hematological malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
Special issue: CAR‐T cell therapy for hematological malignancies
The journey of CAR-T therapy in hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Deubiquitinases in hematological malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies